Meet the Founder
Marcel V. Alavi, Ph.D.
Marcel founded 712 North in 2016 with the goal of targeting the mitochondrial inner membrane proteases to develop therapies for patients with fatal aging-related disease. Marcel recognized the importance of organelle biology more than twenty years ago while still a student at the Ludwig-Maximilians-University in München, Germany, where he graduated with a Masters in Cell Biology & Biochemistry in 2004. Marcel earned his Ph.D. summa cum laude at the Eberhard-Karls University in Tübingen, Germany, in 2010. His research focused on the molecular basis of a genetic form of childhood blindness (ADOA) linked to mitochondrial defects. Until 2016, he held postdoctoral scientist positions at Johannes-Gutenberg University in Mainz, Germany, and the University of California, San Francisco, where he studied intraflagellar transport proteins and vascular basement membrane defects, respectively. Marcel is an inventor on 4 patents and has authored 27 peer-reviewed research articles.
712 North at the BIO Investor Forum 2019 in San Francisco, CA
Contact us
Interested in learning more or working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!